相关实验视频

Updated: Jun 17, 2026

Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery

Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery

Published on: July 31, 2014

低ASPECTS中风患者的M1与M2血栓切除成功的治疗结果

Huanwen Chen¹, Marco Colasurdo², Hidetoshi Matsukawa³

¹Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

|June 18, 2025

概括

低阿尔伯塔中风计划早期CT得分 (ASPECTS) 中风患者的内血管血栓切除术 (EVT) 具有M2封闭,显示有效性降低. 与M1闭塞患者相比,这些患者面临更高的徒劳转血和死亡率.

科学领域:

神经学神经学
干预神经病学干预神经病学
脑卒中医学脑卒中医学

背景情况:

内血管血栓切除术 (EVT) 是急性缺血性中风的关键治疗方法.
在阿尔伯塔中风计划早期CT得分 (ASPECTS) 低,M2段中脑动脉封闭的患者中,EVT的有效性仍然不确定.
低ASPECTS表明风险较小的大脑组织区域,可能会影响治疗结果.

研究的目的:

为了比较EVT在患有低ASPECTS和M2闭塞的患者中的有效性,与M1闭塞相比.
评估结果,如徒劳的再注射,可接受的功能结果和死亡率.
为了确定M2封闭是否代表这个特定的患者群体中更差的预后因素.

主要方法:

多中心回顾性研究,包括患有M1或M2闭塞和低ASPECTS (<6) 的患者,他们接受了成功的EVT.
主要结局:无效的EVT再注血 (90天修改的兰金级别为5或6).
二次结局:可接受的结局 (修改的兰金度数 ≤3),内出血 (ICH),所有原因90天死亡率. 用多变量逻辑回归进行比较.

主要成果:

分析了173名成功接受EVT的患者的低ASPECTS M1或M2封闭.
在M2封闭患者中,无效再输血 (OR 5.48) 和死亡率 (OR 4.90) 的几率明显更高.
与M1封闭患者相比,M2封闭患者的可接受结局几率 (OR 0.33) 也明显较低. 没有发现与ICH有显著的关联.

结论:

在M2闭塞的低ASPECTS中风患者中,成功的EVT与M1闭塞相比,与明显更糟糕的结果有关.
在M2封闭和低ASPECTS的患者中,EVT的疗效可能会降低.
在评估这种易受中风影响的人群中EVT后的预后时,M2阻塞状态是需要考虑的重要因素.

关键词:

在各个方面.M2 已经是M2了一次性中风,中风.一个中等的中等的中等的中等.进行血栓切除术 (thrombectomy).

更多相关视频

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats

Published on: September 17, 2014

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

相关概念视频

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...